Basic Tofranil Information

• INN (International Nonproprietary Name): Imipramine
• Brand Names Available In United Kingdom: Tofranil and generic imipramine hydrochloride or imipramine pamoate formulations
• ATC Code: N06AA02
• Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg (hydrochloride); capsules 75 mg, 100 mg, 125 mg, 150 mg (pamoate)
• Manufacturers In United Kingdom: Novartis (originator Tofranil) and multiple generic manufacturers (e.g., Teva, Mylan, Sandoz)
• Registration Status In United Kingdom: Prescription-only medicine listed on national formularies and licensed via national routes
• OTC / Rx Classification: Prescription-only (Rx)

Major 2022–2025 Studies

Worry: Does new evidence change when clinicians reach for imipramine?

Recent pragmatic trials and systematic reviews from 2022–2025 reinforced imipramine's role in specialist settings for treatment-resistant major depressive disorder and for childhood nocturnal enuresis when behavioural measures were insufficient.

Trials indexed during this period compared tricyclic antidepressants with placebo and with modern agents, and reported clinically meaningful responses in patients refractory to first-line SSRIs or SNRIs.

Imipramine remains highlighted in trials for enuresis where short nocturnal dosing combined with alarm therapy produced modest but consistent reductions in bedwetting frequency among children.

Main Outcomes

What benefits did studies actually show?

Across multiple pragmatic trials, imipramine produced greater reductions in validated depression rating scales than placebo in moderate–severe treatment-resistant cases.

In nocturnal enuresis studies, imipramine reduced wet nights over short courses when added to behavioural measures such as enuresis alarms.

Response rates were higher than placebo but tolerability versus SSRIs favoured the latter in direct comparisons, meaning clinicians often reserve imipramine for later steps in care.

Safety Observations

Is imipramine safe in modern practice?

Safety signals were consistent: anticholinergic effects, orthostatic hypotension and cardiac conduction changes—especially at higher doses—were the most commonly reported concerns.

Pharmacovigilance up to 2025 shows prescription volume decreasing in primary care but continued use in secondary care for complex cases requiring specialist oversight.

Trial protocols and routine care continue to apply ECG screening and seizure-risk assessment before and during therapy.

Layman’s Explanation

Question: How does imipramine help my mood or my child's bedwetting?

Imipramine boosts the brain’s “mood chemicals” that help lift depressed mood.

It also calms overactive bladder signalling at night, which is why it can reduce bedwetting when alarms and behavioural measures alone do not work.

Scientific Breakdown

How does it act on a chemical level?

Imipramine is a prototypical tricyclic antidepressant (ATC N06AA02) that inhibits reuptake transporters for serotonin (5‑HT) and noradrenaline (NA), increasing their synaptic availability.

It also antagonises muscarinic, histamine H1 and α1‑adrenergic receptors, which explains sedative, anticholinergic and hypotensive side effects.

Pharmacokinetics And Dosing Relevance

Why does timing and frequency matter?

Peak plasma concentrations occur 2–6 hours after a dose and the drug has a long half‑life, allowing once‑ or twice‑daily dosing strategies used in trials.

Long half‑life underpins steady‑state approaches and explains why dose changes take several days to fully show effect.

Receptor‑Level Implications

Which side‑effects stem from which receptors?

Muscarinic blockade causes dry mouth, constipation and blurred vision.

α1‑adrenergic blockade causes orthostatic hypotension and dizziness.

At high concentrations imipramine affects cardiac sodium channels, producing conduction delays and cardiotoxicity risk in overdose.

United Kingdom Approvals

Question: Is imipramine licensed for what I need it for in the UK?

Imipramine (INN) is authorised in many jurisdictions for major depression and childhood nocturnal enuresis and is prescription‑only in the UK.

Products appear in NHS formularies as branded Tofranil and as generics in hydrochloride and pamoate salt forms.

In UK practice, prescribers reserve imipramine for resistant depression or short courses for enuresis and follow local trust guidance for monitoring.

Notable Off‑Label Trends

What else do specialists use imipramine for?

Secondary care sometimes uses imipramine off‑label for neuropathic pain, migraine prophylaxis and certain anxiety presentations when first‑line agents fail.

Because of the side‑effect profile and monitoring needs, specialist prescribing is the usual pattern rather than routine primary‑care initiation.

General Dosing

Parents and patients often ask: what dose should I start with?

Adults typically start at 75 mg/day divided and clinicians titrate up according to response and tolerability.

Because of cardiac and anticholinergic risks, the principle is “start low, go slow” with ECG and side‑effect review during up‑titration.

Condition‑Specific Dosing

How do doses vary by condition and age?

Major Depressive Disorder (adults): start 75 mg/day in divided doses and increase cautiously to 150–200 mg/day; severe cases can reach 300 mg/day under specialist supervision.

Elderly and adolescents generally start lower at 25–50 mg/day with close monitoring.

Nocturnal enuresis (children): ages 6–12 typically 25 mg at bedtime (max 50 mg/night); over 12 years 25–50 mg at bedtime (max 75 mg/night).

Hydrochloride tablets (10/25/50 mg) allow fine titration and pamoate capsules (75–150 mg) are used for higher maintenance dosing.

Abrupt cessation is discouraged; tapering reduces withdrawal symptoms.

Contraindications

Who must not take imipramine?

Absolute contraindications include known hypersensitivity to imipramine or other TCAs, recent myocardial infarction and concurrent monoamine oxidase inhibitor (MAOI) therapy.

These situations pose high risk of severe adverse events and the drug must not be started.

Adverse Effects

What side‑effects should patients expect and how serious are they?

Common effects are anticholinergic (dry mouth, constipation, blurred vision), sedation, orthostatic hypotension, weight change and sweating.

Less common effects include tremor, sexual dysfunction and agitation.

Serious risks are cardiotoxicity (conduction delay, arrhythmias) and seizure provocation in predisposed patients; overdose can cause life‑threatening arrhythmias and CNS depression.

Monitoring includes baseline ECG for patients over 50 or with cardiac history, blood pressure lying/standing and liver/renal checks where indicated.

Food Interactions

Can food make imipramine more dangerous or less effective?

There are no major food restrictions, but alcohol markedly potentiates central sedation and orthostatic hypotension, so it should be avoided while taking imipramine.

Advise patients to limit alcohol and to be cautious with large meals that might increase drowsiness.

Drug Combinations To Avoid

Which medicines must not be mixed with imipramine?

Concurrent MAOI therapy is an absolute contraindication because of the risk of serotonin syndrome and hypertensive crises.

High‑risk combinations include other QT‑prolonging drugs, strong CYP inhibitors such as fluvoxamine that raise imipramine levels, other anticholinergics, CNS depressants (benzodiazepines, opioids) and drugs that lower seizure threshold like bupropion or tramadol.

Avoid combining imipramine with class I antiarrhythmics or other drugs that prolong QRS or QT without cardiology input.

Always check OTC medicines and herbal remedies such as St John’s Wort before prescribing.

Survey Data

Do patients say it helps?

Clinic audits in secondary care report many patients experience meaningful improvements in mood or reductions in enuresis frequency when imipramine is used appropriately.

However, bothersome anticholinergic effects and daytime sedation are leading reasons for non‑adherence and discontinuation in primary‑care cohorts.

Forum Trends

What are families and patients saying online?

Forum discussions commonly describe imipramine or Tofranil as effective when SSRIs fail, with repeated advice to use slow titration and monitoring.

Parents using the drug for enuresis report short‑term improvements but emphasise watching for dry mouth, changes in sleep and the need for planned drug‑free intervals.

UK patients highlight the importance of clear explanation about ECG checks, dose adjustments for older patients, and practical side‑effect strategies such as taking doses at bedtime and increasing fibre and fluids.

Supply Chains & Brands

Where does Tofranil come from and who makes it?

Tofranil is the originator brand from Novartis and imipramine is widely available as generics manufactured by companies like Teva, Mylan and Sandoz.

Formulations on the market include imipramine hydrochloride tablets and imipramine pamoate capsules supplied through wholesalers, hospital pharmacies and community pharmacies.

UK Pricing Trends

Is imipramine expensive on the NHS or privately?

Generic competition has reduced cost substantially and NHS procurement typically favours the lowest‑cost supplier listed on local formularies.

Occasional shortages affect particular strengths or salt forms and may require therapeutic substitution between hydrochloride tablets and pamoate capsules with appropriate clinical oversight.

Comparison Table

Looking for alternatives to imipramine?

Other tricyclics include amitriptyline and nortriptyline; SSRIs such as fluoxetine and sertraline are usual first‑line antidepressants in UK pathways.

Pros And Cons

When might imipramine be the right choice?

Pros: effective in treatment‑resistant depression, long clinical experience, and useful short‑term option for nocturnal enuresis.

Cons: higher anticholinergic burden, orthostatic hypotension, cardiotoxicity risk and need for ECG and monitoring make it less attractive than SSRIs as an initial choice.

Use imipramine when SSRIs/SNRIs have failed, when comorbid enuresis is present, or for neuropathic indications where TCAs are effective.

Approvals And Licences

What does the regulator say?

Imipramine is classified ATC N06AA02 and is approved by the FDA for depression and childhood nocturnal enuresis; EMA and national licensing routes authorise its use in EU countries and it remains prescription‑only in the UK.

Clinicians should consult current SPCs and local trust policies when prescribing.

Labelling & Prescription Status

How is imipramine labelled and supplied?

Product information lists tablets (10/25/50 mg) and pamoate capsules (75–150 mg) with dosing tables, contraindications and storage guidance at 20–25°C.

Prescribe as a POM and report suspected adverse reactions to the MHRA Yellow Card scheme.

Common Questions

Patients often ask: Is Tofranil available in the UK?

Yes—Tofranil and generic imipramine formulations are available in the UK but are prescription‑only medicines supplied via NHS or community pharmacies.

Quick Answers

Is imipramine first line?

No—SSRIs are typically first line for depression in the UK; imipramine is used for resistant cases or for enuresis when behavioural measures fail.

How long to see effect?

Antidepressant response generally takes several weeks; enuresis benefit may be seen sooner when combined with alarm therapy.

What monitoring is needed?

Baseline ECG for patients over 50 or with cardiac history, orthostatic BP checks, liver/renal assessment where indicated and review for anticholinergic symptoms.

Can I stop suddenly?

No—taper to avoid withdrawal symptoms.

What about overdose?

Overdose is a medical emergency with risk of seizures and arrhythmias; urgent hospital care is required.

Tablet & Capsule Forms

How do I recognise imipramine in the pack?

UK products commonly include imipramine hydrochloride tablets in 10 mg, 25 mg and 50 mg strengths, and imipramine pamoate capsules in 75–150 mg strengths.

Scored tablets permit splitting for dose adjustment and pamoate capsules serve higher maintenance doses.

Key Pictograms & Labelling

What should patients look for on the box and leaflet?

Packaging displays the INN imipramine or the brand Tofranil, strength, dosing instructions (often “Take at bedtime”), POM status and warnings about MAOI interactions and cardiac history.

Patient leaflets should include icons advising “Do not drive until you know how it affects you”, “Avoid alcohol” and “Report palpitations or severe dizziness”.

Recommended Conditions

How should imipramine be stored?

Store at 20–25°C, protected from moisture and light, and keep out of reach of children.

Transport at ambient temperature is acceptable for UK distribution; avoid prolonged exposure to extremes of heat or humidity during shipping.

Supply‑Chain Considerations

What happens if a batch is unavailable?

Supply shortages sometimes necessitate switching between hydrochloride and pamoate salts; pharmacies must document the change and counsel patients about any difference in appearance or dosing strategy.

Unused medicine should be returned to pharmacy for safe disposal.

Prescriber Checklist

What should a clinician confirm before starting imipramine?

Confirm indication, review cardiac history and current medicines, avoid MAOI co‑prescription, obtain baseline ECG for older patients or those with cardiac disease, consider hepatic/renal function and plan a review in 2–4 weeks.

Patient Instructions

What should patients know before they start?

Take as directed, usually at bedtime to reduce daytime sedation.

Do not double up doses if you miss one; avoid alcohol and be cautious driving until you know how it affects you.

Report palpitations, severe dizziness, urinary retention or signs of serotonin syndrome promptly.

Taper gradually when stopping.

Common Questions From Parents

How is enuresis treatment planned for children?

Use short courses (1–3 months) with behavioural adjuncts such as enuresis alarms and plan drug‑free intervals to reassess the need for ongoing therapy.

Emergency Advice

What to do in an overdose?

Seek immediate emergency care; hospital management may include cardiac monitoring, seizure control and supportive measures such as gastric decontamination according to local emergency protocols.

Visual Identification Tips

How to avoid dispensing errors?

Match the INN and strength on the prescription to the pack and check whether the product is hydrochloride tablet or pamoate capsule before handing it out.

Use pictograms in counselling to show “take at bedtime”, “avoid alcohol” and “report dizziness”.

Record‑Keeping And Traceability

What should pharmacies document?

Keep batch numbers and expiry dates for pharmacovigilance and Yellow Card reporting purposes.

When substituting between brands or salt forms, note the change and advise the patient.

Prescribing Checklist (Quick)

Ensure the indication is correct, check ECG if indicated, start at recommended dose for age, counsel on side effects and arrange follow‑up.

Patient Leaflet Tips

Provide written advice on dose timing, side‑effect management (hydration, fibre for constipation) and what to do in emergencies.

Delivery Across United Kingdom

Final Practical Notes

Concern: How to access Tofranil safely and legally?

Imipramine is prescription‑only in the UK and should be dispensed against a valid prescription supplied by an authorised prescriber.

Note: In our online pharmacy, tofranil is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Any off‑label use should be documented with patient consent and supported by specialist advice where appropriate.

Report suspected serious adverse reactions to the MHRA Yellow Card scheme and keep clear monitoring records when using imipramine in adults or children.